FDA Reveals Plan To Speed Up Generic Drug Review

Law360, New York (October 4, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration has unveiled a new program designed to speed up the process of getting generic drugs approved and to hasten the market entry of the less expensive generics.

The program - Generic Initiative for Value and Efficiency, or GIVE - revealed Thursday, aims to make the generic drug review process at the FDA significantly more productive in response to increases in the number of generic drug applications filed with the FDA.

The agency said it had approved or tentatively approved 682...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.